Iladatuzumab vedotin
Synonyms: DCDS0780A;RO7032005
Iladatuzumab vedotin (DCDS0780A;RO7032005) is an antibody-drug conjugate (ADC) composed of CD79B (immunoglobulin-associated CD79 beta) antibody and cytotoxic agent monomethyl auristatin E (MMAE) conjugated through maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl (mc-val-cit-PABC) type linker. Iladatuzumab vedotin has the potential for B-cell non-Hodgkin lymphoma (B-NHL) research.
CAS No. 1906205-77-3
Click to purchase products related to
Quality Control
Specificity
2. "✔" indicates inhibitory effect, but without specific value.
Mechanism of Action
| Description |
Iladatuzumab vedotin (DCDS0780A;RO7032005) is an antibody-drug conjugate (ADC) composed of CD79B (immunoglobulin-associated CD79 beta) antibody and cytotoxic agent monomethyl auristatin E (MMAE) conjugated through maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl (mc-val-cit-PABC) type linker. Iladatuzumab vedotin has the potential for B-cell non-Hodgkin lymphoma (B-NHL) research.
|
References |
|---|
Product Details
| CAS No. | 1906205-77-3 |
|---|---|
| ADC antibody | Iladatuzumab |
| ADC cytotoxin | MMAE |
| Formulation | 1xPBS |
| Storage | Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
Comparison of Clones for
*Literature analysis of various clone (for this target) products available on the market shows that Sellecks selected clones are more frequently applied. (data until September 2024)
Tech Support
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.
Products are for research use only. Not for human use. We do not sell to patients.
©Copyright 2013 Selleck Chemicals. All Rights Reserved.